Abstract:Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is a major cause of stroke and morbidity. Recent genome-wide association studies have shown that paired-like homeodomain transcription factor 2 (Pitx2) to be strongly associated with AF. However, the mechanisms underlying Pitx2 modulated arrhythmogenesis and variable effectiveness of antiarrhythmic drugs (AADs) in patients in the presence or absence of impaired Pitx2 expression remain unclear. We have developed multi-scale computer models, ranging from a single cell to tissue level, to mimic control and Pitx2-knockout atria by incorporating recent experimental data on Pitx2-induced electrical and structural remodeling in humans, as well as the effects of AADs. The key findings of this study are twofold. We have demonstrated that shortened action potential duration, slow conduction and triggered activity occur due to electrical and structural remodelling under Pitx2 deficiency conditions. Notably, the elevated function of calcium transport ATPase increases sarcoplasmic reticulum Ca<sup>2+</sup> concentration, thereby enhancing susceptibility to triggered activity. Furthermore, heterogeneity is further elevated due to Pitx2 deficiency: 1) Electrical heterogeneity between left and right atria increases; and 2) Increased fibrosis and decreased cell-cell coupling due to structural remodelling slow electrical propagation and provide obstacles to attract re-entry, facilitating the initiation of re-entrant circuits. Secondly, our study suggests that flecainide has antiarrhythmic effects on AF due to impaired Pitx2 by preventing spontaneous calcium release and increasing wavelength. Furthermore, our study suggests that Na<sup>+</sup> channel effects alone are insufficient to explain the efficacy of flecainide. Our study may provide the mechanisms underlying Pitx2-induced AF and possible explanation behind the AAD effects of flecainide in patients with Pitx2 deficiency.Atrial fibrillation (AF) is an abnormal heart rhythm that can lead to stroke and death. Recent studies have uncovered that AF-associated risk variants are adjacent to the Pitx2 locus, furthermore, the have demonstrated that AF patients with these variants respond better to certain antiarrhythmic drugs (AADs). However, the mechanisms underlying Pitx2 modulated arrhythmogenesis and variable effectiveness of AADs remain unclear. To untangle this issue, we have developed multi-scale computer models, ranging from single cell to tissue level, to mimic control and the Pitx2-knockout atria by incorporating experimental data on Pitx2-induced electrical and structural remodelling, as well as the effects of class I ADDs (flecainide). We discovered that removal of Pitx2 caused AF characterized by focal beats and re-entrant waves. It was found that these abnormalities can be attributed to triggered beats, action potential duration shortening and slow conduction arising from Pitx2-induced remodelling. Interestingly, these Pitx2-induced AF can be suppressed in the presence of class I AADs such as flecainide. Our simulations revealed that flecainide prevents triggered beats by blocking the function of ryanodine receptors and that flecainide can terminate re-entrant waves by prolonging action potential duration due to its actions on potassium channels.

PITX2C Loss-of-function Mutations Responsible for Idiopathic Atrial Fibrillation

A Novel Pitx2c Loss-Of-Function Mutation Underlies Lone Atrial Fibrillation

TBX5 Mutations Contribute to Early-Onset Atrial Fibrillation in Chinese and Caucasians.

PITX2c Loss-of-function Mutations Responsible for Congenital Atrial Septal Defects.

A Novel PITX2c Gain-of-Function Mutation, p.Met207Val, in Patients With Familial Atrial Fibrillation.

Mutation screen of pulmonary myocardium development gene pituitary homeobox 2 in Chinese patients with isolated atrial fibrillation

KCNQ1 Gain-of-function Mutation in Familial Atrial Fibrillation

Identification of A Novel Frameshift Mutation in Pitx2 Gene in A Chinese Family with Axenfeld-Rieger Syndrome

A Kir2.1 Gain-of-function Mutation Underlies Familial Atrial Fibrillation.

Identification of a KCNE2 Gain-of-Function Mutation in Patients with Familial Atrial Fibrillation

PITX2 Loss-of-Function Mutation Contributes to Congenital Endocardial Cushion Defect and Axenfeld-Rieger Syndrome.

In Silico Assessment of Genetic Variation in PITX2 Reveals the Molecular Mechanisms of Calcium-Mediated Cellular Triggered Activity in Atrial Fibrillation.

PITX2 gain-of-function mutation associated with atrial fibrillation alters mitochondrial activity in human iPSC atrial-like cardiomyocytes

Prevalence and Spectrum of Nkx2.5 Mutations Associated with Idiopathic Atrial Fibrillation

Novel PITX2c Loss-of-function Mutations Associated with Complex Congenital Heart Disease.

[Identification and Functional Analysis of a KCNA5 Mutation Responsible for Idiopathic Atrial Fibrillation].

Proarrhythmia in the P.met207val PITX2c-Linked Familial Atrial Fibrillation-Insights from Modeling.

PITX2 Upregulation Increases the Risk of Chronic Atrial Fibrillation in a Dose-Dependent Manner by Modulating IKs and ICaL -Insights from Human Atrial Modelling.

Prevalence and Spectrum of PITX2c Mutations Associated with Congenital Heart Disease.

In silico investigation of the mechanisms underlying atrial fibrillation due to impaired Pitx2

Pitx2c deficiency confers cellular electrophysiological hallmarks of atrial fibrillation to isolated atrial myocytes